MedTrace Logo

Writing to Alleviate Violence Exposure for Transgender Women (WAVE-TW)

NCT04305977 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-02-17

No results posted yet for this study

Summary

WAVE - TW (Writing to Alleviate Violence Exposure for Transgender women living with HIV) is an intervention development study which aims to assess the feasibility and acceptability of a proposed trauma writing and adherence intervention that addresses Post-Traumatic Stress Disorder (PTSD) and depressive symptoms, antiretroviral therapy (ART) adherence and viral suppression among transgender women.

Conditions

Interventions

BEHAVIORAL

WAVE-TW

The WAVE-TW open pilot trial of the intervention consists of 5 sessions conducted individually with each part participant. Each session lasts approximately 30-50 minutes. The first session will be the LifeSteps Adherence session that focuses on cognitive-behavioral and problem-solving techniques to promote adherence. The next four sessions will be dedicated to trauma writing.

Sponsors & Collaborators

  • Empower U Community Health Center

    collaborator UNKNOWN

  • Miami Center for AIDS Research at the University of Miami Miller School of Medicine

    collaborator UNKNOWN

  • University of Miami

    lead OTHER

Principal Investigators

  • Sannisha Dale, PhD · University of Miami

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-22
Primary Completion
2021-10-15
Completion
2021-10-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04305977 on ClinicalTrials.gov